Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041726 | SCV000065422 | benign | not specified | 2008-02-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000041726 | SCV000169768 | benign | not specified | 2011-07-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000041726 | SCV000231909 | benign | not specified | 2015-01-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000041726 | SCV000317192 | benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV001511032 | SCV000884831 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001511032 | SCV001718206 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001271123 | SCV001748491 | benign | Usher syndrome type 2A | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000041726 | SCV003928754 | benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003887889 | SCV004707263 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV001511032 | SCV005287605 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001271123 | SCV001451974 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |